NANOTRANSMED is a European project, led by a french-german-swiss consortium and cofinanced by the INTERREG VA Upper Rhine Programme.
NANOTRANSMED enables French, German and Swiss scientists to develop together applications and innovations in nanomedicine.
The NANOTRANSMED consortium focuses in particular on issues concerning early, reliable and fast diagnosis but also personalized treatment of diseases such as cancers and inflammation as well as issues regarding nosocomial infections contracted by 5% of hospitalized patients.
Company Details
- Founded
- -
- Address
- Cnrs Ipcms, Rue Du Loess, Strasbourg,rhin Supérieur,france
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- http://www.nanotransmed.eu
- Keywords
- Nanomedicine, Biomaterials, Circulating Materials, Implants, Nano-object/living environment interaction, Photothermal therapy, MRI, Microbubbles, Optoacoustic imaging, Magnetic hyperthermia, Protein corona, Anti-fouling properties.
- HQ
- Strasbourg, Rhin Supérieur
Nanotransmed Questions
Nanotransmed's website is http://www.nanotransmed.eu
Nanotransmed's LinkedIn profile is https://fr.linkedin.com/company/nanotransmed
Nanotransmed's industry is
Nanotechnology Research
Nanotransmed's top competitors are
Oregon Physics,
Eipbn,
Dyteqta Ltd,
Esme Valves Limited,
Vacgen Ltd,
Drallim Industries Limited,
Adamco Inc.,
Dorman Hill Ltd,
Uhv Design Ltd,
Metaltech Precision Engineers Ltd.
Nanotransmed's categories are Nanotechnology Research
Nanotransmed's founding year is 2016
